Fusilev

Here's a quick look at nine of the best-performing biotech stocks of the past year. Achillion Pharmaceuticals (NASDAQ: ACHN) is up almost 88% year to date and about 37% higher just in the past month. This Connecticut-based biopharmaceutical company has three drugs in clinical trials to treat...

Auriga has published a research report on Spectrum Pharmaceuticals (NASDAQ: SPPI) commenting on the generic drug application for Fusilev. In the report, Auriga writes, "A company filed a generic drug application that challenges the Fusilev orange book listed patent. The market reacted negatively...